DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
02 1FARMHISPANIA GROUP (SUISSE) SA Lugano CH
03 2ARCH PHARMALABS LIMITED Mumbai IN
04 1CIPLA LIMITED Mumbai IN
05 1Eli Lilly And Company Indianapolis US
06 3FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN
07 1FUAN PHARMACEUTICAL GROUP NINGBO TEAM PHARMACEUTICAL CO., LTD. Ningbo CN
08 2HETERO LABS LIMITED Hyderabad IN
09 2INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
10 1JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. Lianyungang City CN
11 1LAURUS LABS LIMITED Hyderabad IN
12 1LAURUS LABS PRIVATE LIMITED Hyderabad IN
13 1RAVI BIOLIFE PRIVATE LTD. Mumbai IN
14 1SCINOPHARM TAIWAN, LTD. Shan-Hua TW
15 2SHILPA PHARMA LIFESCIENCES LIMITED Raichur IN
16 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
17 2TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
18 1Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City CN
01 16Gemcitabine hydrochloride
02 1Gemcitabine hydrochloride, Alternate Process-2
03 1Gemcitabine hydrochloride, Alternate process
04 1Gemcitabine hydrochloride, GA process
05 1Gemcitabine hydrochloride, Process III
06 2Gemcitabine hydrochloride, Process-2
07 1Gemcitabine hydrochloride, Product code: GAI
08 1Gemcitabine hydrochloride, Product code: GMI
09 1Gemcitabine hydrochloride, alpha-Mesylribose process
01 3China
02 16India
03 2Israel
04 1Spain
05 1Taiwan
06 1U.S.A
07 1Blank
01 1Expired
02 20Valid
03 2Withdrawn by EDQM Failure to CEP procedure
04 2Withdrawn by Holder
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 2007-075 - Rev 06
Status : Valid
Issue Date : 2021-06-18
Type : Chemical
Substance Number : 2306
Certificate Number : R1-CEP 2011-032 - Rev 01
Status : Valid
Issue Date : 2017-09-27
Type : Chemical
Substance Number : 2306
Gemcitabine Hydrochloride, Alternate Process-2
Certificate Number : CEP 2023-271 - Rev 00
Status : Valid
Issue Date : 2023-12-06
Type : Chemical
Substance Number : 2306
Certificate Number : R1-CEP 2009-042 - Rev 01
Status : Valid
Issue Date : 2015-10-16
Type : Chemical
Substance Number : 2306
Certificate Number : CEP 2017-076 - Rev 01
Status : Valid
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 2306
Gemcitabine Hydrochloride, Process III
Certificate Number : CEP 2022-092 - Rev 01
Status : Valid
Issue Date : 2024-09-02
Type : Chemical
Substance Number : 2306
Certificate Number : R1-CEP 2009-026 - Rev 02
Status : Valid
Issue Date : 2023-01-24
Type : Chemical
Substance Number : 2306
Certificate Number : CEP 2006-272 - Rev 07
Status : Valid
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 2306
Certificate Number : CEP 2007-021 - Rev 02
Status : Valid
Issue Date : 2024-06-12
Type : Chemical
Substance Number : 2306
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2023-229 - Rev 00
Status : Valid
Issue Date : 2024-08-05
Type : Chemical
Substance Number : 2306
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Gemcitabine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gemcitabine Hydrochloride, including repackagers and relabelers. The FDA regulates Gemcitabine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gemcitabine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gemcitabine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gemcitabine Hydrochloride supplier is an individual or a company that provides Gemcitabine Hydrochloride active pharmaceutical ingredient (API) or Gemcitabine Hydrochloride finished formulations upon request. The Gemcitabine Hydrochloride suppliers may include Gemcitabine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Gemcitabine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gemcitabine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Gemcitabine Hydrochloride Certificate of Suitability (COS). The purpose of a Gemcitabine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gemcitabine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gemcitabine Hydrochloride to their clients by showing that a Gemcitabine Hydrochloride CEP has been issued for it. The manufacturer submits a Gemcitabine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gemcitabine Hydrochloride CEP holder for the record. Additionally, the data presented in the Gemcitabine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gemcitabine Hydrochloride DMF.
A Gemcitabine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gemcitabine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gemcitabine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
We have 16 companies offering Gemcitabine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?